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Abstract
Crypt abscesses caused by excessive neutrophil accumulation are prominent features of human
campylobacteriosis and its associated pathology. The molecular and cellular events responsible for
this pathological situation are currently unknown. We investigated the contribution of PI3Kγ
signaling in Campylobacter jejuni-induced neutrophil accumulation and intestinal inflammation.
Germ-free and specific pathogen free Il10−/−and germ-free Il10−/−; Rag2−/− mice were infected
with C. jejuni (109 CFU/mouse). PI3Kγ signaling was manipulated using either the
pharmacological PI3Kγ inhibitor AS252424 (i.p. 10 mg/kg daily) or genetically using Pi3γ−/−
mice. After up to 14 days, inflammation was assessed histologically and by measuring levels of
colonic Il1β, Cxcl2 and Il17a mRNA. Neutrophils were depleted using anti-Gr1 antibody (i.p. 0.5
mg/mouse/every 3 days). Using germ-free Il10−/−; Rag2−/− mice, we observed that innate immune
cells are the main cellular compartment responsible for campylobacteriosis. Pharmacological
blockade of PI3Kγ signaling diminished C. jejuni-induced intestinal inflammation, neutrophil
accumulation and NF-κB activity, which correlated with reduced Il1β (77%), Cxcl2 (73%) and
Il17a (72%) mRNA accumulation. Moreover, Pi3kγ−/− mice pretreated with anti-IL-10R were
resistant to C. jejuni-induced intestinal inflammation compared to Wt mice. This improvement
was accompanied by a reduction of C. jejuni translocation into the colon and extra-intestinal
tissues and by attenuation of neutrophil migratory capacity. Furthermore, neutrophil depletion
attenuated C. jejuni-induced crypt abscesses and intestinal inflammation. Our findings indicate
that C. jejuni-induced PI3Kγ signaling mediates neutrophil recruitment and intestinal
inflammation in Il10−/− mice. Selective pharmacological inhibition of PI3Kγ may represent a
novel means to alleviate severe cases of campylobacteriosis, especially in antibiotic-resistant
strains.
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Campylobacter jejuni is the leading cause of food borne bacterial infection worldwide and
has a prevalence of 14 laboratory-confirmed cases/100,000 persons in 2011 in the United
States (1). This infection rate is the second highest incidence and higher than the following
eight most common pathogens combined ( 9.1/100,000) (1). Symptoms of Campylobacter
infection are generally self-limited and include diarrhea, abdominal cramps and fever (2).
However, severe cases involving bloody diarrhea, prolonged fever and severe cramping
require antibiotic treatment. Importantly, campylobacteriosis is associated with development
of extra-intestinal sequelae such as Guillain-Barre Syndrome (3), reactive arthritis(4),
relapse of inflammatory bowel diseases (IBD)(5) and post-infectious irritable bowel
syndrome (6). These numerous sequelae in conjunction with increased resistance to
antibiotic treatment position campylobacter an important enteric pathogen and demand an
improvement in both prevention and management (7, 8). Although campylobacteriosis
represents a major health concern in both the developing and industrialized world, our
understanding of the basic molecular and cellular events associated with Campylobacter
infection is rather primitive compared to other pathogens with less prevalence (Shigella,
Escherichia, Vibrio, Listeria) (9). This gap of knowledge is in stark contrast with the
relatively well characterized molecular genetic information of the bacterium. Indeed, the
publication of various campylobacter genomes, included C. jejuni 81–176 has contributed to
a better understanding of the microbial genetic elements controlling growth, survival and
fitness (10, 11). Our limited understanding of Campylobacter pathogenesis likely stems from
the poor availability of murine models. We and others have recently showed that Il10−/−
mice represent a powerful model to study colonization, infection, bacterial translocation and
inflammatory responses (12–14). Moreover, a recent study showed that the colon of C.
jejuni infected Il10−/− mice showed increased expression of the chemoattractant Cxcl2
which correlates with the formation of numerous crypt abscesses and neutrophil infiltration,
a phenotype commonly observed in human campylobacteriosis (13, 15). Similarly, CXCL-2
mediates neutrophil recruitment into intestinal payer’s patches (PP) and MLN in
Salmonella-infected mice (16), therefore this chemokine may play an important role in
campylobacteriosis.
Phosphatidylinositol 3-kinases (PI3Ks) are a large family of signaling proteins formed by a
catalytic subunit and a regulatory subunit. These signaling proteins are grouped into three
different classes (I, II and III) and are implicated in the regulation of cell growth,
proliferation, differentiation, survival and motility (17). In addition, a number of recent
reports implicate various PI3K proteins in innate and adaptive immunity (17, 18). PI3Kγ is
a class I B PI3K and comprises a catalytic subunit (p110γ) and a regulatory subunit (p101 or
p84). PI3Kγ is mainly expressed in immune cells and mediates chemoattractant-induced cell
migration by controlling actin cytoskeletal rearrangement through G-protein coupled
receptors (19, 20). Interestingly, neutrophils isolated from Pi3kγ−/− mice show impaired
migration towards N-formyl-methionyl-leucyl-phenylalanine (fMLP) due to reduced F-actin
accumulation at the cell’s leading edge (21). In addition, Pi3kγ−/− mice injected i.p. with
Listeria exhibited reduced neutrophil accumulation into the peritonea compared to Wt mice
(20).
We recently found that C. jejuni induced intestinal inflammation is associated with
neutrophil infiltration (13), although the functional impact and molecular events leading to
this response remained elusive. In present study, we hypothesized that neutrophil
recruitment into intestinal crypts and the associated tissue destruction observed in C. jejuni
infected hosts are mediated through PI3Kγ signaling and neutrophil recruitment. Using
pharmacological and genetic approaches, we demonstrated that PI3Kγ signaling promotes
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C. jejuni-induced colitis by regulating the influx of neutrophils into intestinal crypts. This
signaling pathway may represent a new therapeutic target for campylobacteriosis.
MATERIALS AND METHODS
Mice and tissue processing
All animal protocols were approved by the Institutional Animal Care and Use Committee of
the University of North Carolina at Chapel Hill. Germ-free 8–12 week-old Il10−/−; NF-
κBEGFP (129/SvEv; C57BL/6 mixed background), Il10−/− and Il10−/−; Rag2−/− mice (129/
SvEv) were transferred from germ-free isolators and immediately gavaged with a single
dose of 109 C. jejuni cfu/mouse (strain 81–176(22)) and sacrificed after up to 14 days as
described previously (13). Specific pathogen free (SPF) housed Wt, Il10−/− and Pi3kγ−/−
(20) mice (generous gift of Dr. Emilio Hirsch, Univerisity of Torino, Italy) all on a 129/
SvEv background were gavaged 109 C. jejuni cfu/mouse one day after 7 day treatment with
antibiotics cocktail (streptomycin 2 g/L, gentamycin 0.5 g/L, bacteriocin 1 g/L and
ciprofloxacin 0.125 g/L) (13). To inhibit PI3K and PI3Kγ signaling, mice were i.p. injected
daily with wortmannin (1.4 mg/kg; Fisher Scientific) and AS252424 (10 mg/kg; Cayman
Chemical), respectively. Tissue samples from colon, spleen, and mesenteric lymph nodes
(MLN) were collected for protein, RNA, histology and C. jejuni culture assays as described
previously (13). Histological images were acquired using a DP71 camera and DP Controller
3.1.1.276 (Olympus), and intestinal inflammation was scored on a scale of 0 – 4 as described
before (12, 13). Neutrophils in colonic tissues were identified based on morphological
features using H&E stained sections and counted in 5 fields of view/mouse using a
microscope. Data were expressed as average counts/mouse.
Neutrophil depletion and IL-10 receptor blockade
Il10 −/−; NF-κBEGFP mice were infected with C. jejuni and injected with anti-Gr1 antibody
(i.p. 0.5 mg/mouse, at D0 and D3; clone: RB6-8C5; BioXcell) for 6 days to deplete
neutrophil as described in a previous reports (23). We selected a 6 day experimental time
instead of the typical 12 days because neutrophil depletion is less effective after 6 days (Sun
and Jobin, personal observation). To block IL-10 signaling, antibiotic treated and C. jejuni
infected Wt and Pi3kγ−/− mice were injected with anti-IL-10R antibody (i.p. 0.5 mg/mouse,
every 3 days; Clone: 1B1.3A;BioXcell) for 14 days as described (24). At the end of the
experiment, mice were euthanized using CO2 intoxication and death was ensured by
performing cervical dislocation. Colons were resected and processed for H&E staining and
colitis evaluation.
Western blotting
A segment of the distal colon was lysed in 300 μl Laemmli buffer, homogenized and heated
at 95 °C for 5 min. 20 μg of total protein were separated by SDS-PAGE and transferred to
nitrocellulose membranes. Targeted protein was detected using enhanced
chemiluminescence reaction (ECL) as described previously (25). Primary antibodies used
were phosphor-AKT (S473), phosphor-p70S6K (T389), total AKT (all from Cell Signaling)
and EGFP (Sigma). The density of Western blot bands was quantified using ImageJ and data
were normalized to total AKT control.
Neutrophil isolation and migration assay
Neutrophils from the peripheral blood were isolated as described (26). Briefly, blood (~1 ml/
mouse, 8 mice/group) from Wt and Pi3k−/− mice was collected in 5mM EDTA by cardiac
puncture. The blood was diluted with 0.15M NaCl, loaded on a single layer of 69.2% Percoll
and centrifuged at 1500× g for 20 min at room temperature. Neutrophils were recovered at
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the bottom layer of the gradients, and contaminating erythrocytes were lysed by hypotonic
shock. Neutrophil purity was assessed using Wright-Giemsa staining and was found to be >
98 %. Cell migration assay was performed immediately after purification. A total of 5×105
neutrophils were added in the top chamber of a Transwells (12 wells with 3 μm pore;
Corning Inc., Corning, NY) and CXCL-2 (250 ng/mL; R&D Systems) was added to the
bottom wells. RMPI 1640 medium without CXCL-2 was used as a negative control.
Transwells were then incubated for 2 h in humidified air and 5% CO2. Neutrophils migrated
into the bottom wells were imaged using a DP71 camera and DP Controller 3.1.1.276
(Olympus) and enumerated using a hemocytometer (Sigma-Aldrich). Cell viability was
more than 95% as judged by trypan blue exclusion.
Enhanced GFP (EGFP) macro-imaging
Following infection and various treatment, Il10 −/−; NF-κBEGFP mice were sacrificed, and
the colon and cecum were removed and immediately imaged using a charge-coupled device
camera in a light-tight imaging box with a dual-filtered light source and emission filters
specific for EGFP (LT-99D2 Illumatools; Lightools Research).
Fluorescence in situ hybridization (FISH)
Cy3-tagged 5′AGCTAACCACACCTTATACCG3′ was used to probe the presence of C.
jejuni in the intestinal tissue sections as previously described (13). Briefly, tissues were
deparaffinized, hybridized with the probe, washed, mounted in DAPI medium and imaged
using a Zeiss LSM710 Spectral Confocal Laser Scanning Microscope system with ZEN
2008 software. Acquired images were analyzed using BioimageXD (27).
Immunohistochemistry (IHC)
Neutrophils in intestinal tissue were detected using anti-myeloperoxidase (MPO) IHC as
described previously (13). Briefly, intestinal tissue sections were deparaffinized, blocked
and incubated with an anti-MPO antibody (1:400; Thermo Scientific) overnight. After
incubation with anti-rabbit biotinylated antibody, ABC (Vectastain ABC Elite Kit, Vector
Laboratories), DAB (Dako) and hematoxylin (Fisher Scientific), the sections were imaged
on an Olympus microscope using DP 71 camera and DP Controller 3.1.1.276 (Olympus).
C. jejuni quantification in tissues
MLN and spleen were aseptically resected. Colon tissue was opened, resected and washed
three times in sterile PBS. The tissues were weighed, homogenized in PBS, serially diluted
and plated on Campylobacter selective blood plates (Remel) for 48 h at 37 °C using the
GasPak system (BD). C. jejuni colonies were counted and data presented as colony forming
unit (cfu)/g tissue.
Real time RT-PCR
Total RNA from intestinal tissues was extracted using TRIzol (Invitrogen) following the
manufacture’s guide. cDNA was reverse-transcribed using M-MLV (Invitrogen).
Proinflammatory Il1β, Cxcl2, Il17a and Tnfα mRNA expression levels were measured using
SYBR Green PCR Master mix (Applied Biosystems) on an ABI 7900HT Fast Real-Time
PCR System and normalized to Gapdh. The PCR primers used were reported previously.
(13) The PCR reactions were performed for 40 cycles according to the manufacturer’s
recommendation, and RNA fold changes were calculated using the ΔΔct method.
Primary splenocyte isolation and C. jejuni infection
Splenocytes were isolated as described previously.13 Briefly, Wt and Pi3kγ−/− mice (8–12
wk-old) were sacrificed, spleens were resected and homogenized in RPMI 1640 medium
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supplemented with 2% fetal bovine serum (FBS), 2mM L-glutamine and 50μM 2-
mercaptoethanol. Red blood cells were lysed, and cells were filtered through a 70 μm
strainer, centrifuged, resuspended in the2% FBS RPMI 1640 medium and plated at 1×106
cells/well in 6-well plates. Cells were infected with C. jejuni (MOI 50) for 4h in triplicates.
Cells were then collected by centrifugation and lysed in TRIzol (Invitrogen) for RNA
extraction.
C. jejuni epithelial cell translocation assay
Murine rectal carcinoma epithelial CMT-93 cells (1×106) were plated onto 12-well
Transwells (Corning Inc., Corning, NY) in DMEM media containing 10% FBS and 2mM L-
glutamine. Upon reached confluency (monolayer), the medium was changed to 1% FBS
medium and 108 C. jejuni was added to the upper inserts in presence or absence of 10 μM
AS252424. Aliquot of medium from bottom wells was collected every hr for 5 hrs, serially
diluted and cultured on Remel plates as described before (13). Translocated C. jejuni was
reported as CFU/ml at each time point.
Statistical analysis
Values are shown as mean ± SEM as indicated. Differences between groups were analyzed
using the nonparametric Mann-Whitney U test. Experiments were considered statistically
significant if P values < 0.05. All calculations were performed using Prism 5.0 software.
RESULTS
Innate immune cells mediate C. jejuni-induced colitis
We have previously demonstrated using antibody depletion approach that C. jejuni-induced
colitis in Il10−/− mice is CD4 independent (13). To further establish the role of innate and
adaptive immunity in campylobacteriosis, we utilized germ-free Il10−/−; Rag2−/−mice.
Germ-free Il10−/− and Il10−/−; Rag2−/− mice were transferred to specific pathogen free
(SPF) housing and immediately gavaged with a single dose of C. jejuni (109 CFU/mouse).
After 12 days, as previously reported, C. jejuni induced severe intestinal inflammation in
Il10−/− mice as showed by extensive immune cell infiltration, epithelial damage, goblet cell
depletion and crypt hyperplasia and abscesses compared to uninfected mice (Figures 1A-B).
Interestingly, the absence of T and B cells did not impact the severity of colitis, as C. jejuni-
infected Il10−/−; Rag2−/− and Il10−/− mice developed comparable levels of intestinal
inflammation. Similarly, C. jejuni-induced I11β, Cxcl2 and Il17a mRNA accumulation was
not significantly different between Il10−/−; Rag2−/− and Il10−/− mice (Figure 1C).
Altogether, these observations indicate that C. jejuni-induced intestinal inflammation is
predominantly mediated by innate immune cells during the early onset of
campylobacteriosis (12 days).
PI3K signaling mediates C. jejuni-induced colitis
We previously showed that mTOR mediates C. jejuni-induced colitis (13) and since PI3K
signaling is a potential upstream regulators of mTOR, we hypothesized that this pathway
plays an important role in campylobacteriosis. To test this hypothesis, C. jejuni-infected
germ-free Il10−/−; NF-κBEGFP mice were i.p. injected daily with either vehicle (5% DMSO
PBS) or with the pharmacological PI3K pan-inhibitor wortmannin (1.4 mg/kg body weight)
for 12 days. As seen in Figures 2A–B, C. jejuni-induced colitis and crypt abscesses were
reduced in wortmannin-treated mice compared to vehicle-treated mice. Western blot
analysis demonstrated reduction of C. jejuni-induced Akt phosphorylation (S473) in colonic
lysates from wortmannin-treated, C. jejuni-infected mice (Figure 2C). Moreover, C. jejuni-
induced AKT phosphorylation (S473) in colonic lysates was not impaired in Il10−/−;
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Rag2−/− mice, suggesting that lymphocytes are not the main contributor of Akt
phosphorylation (Supplemental Figure 1).
To evaluate whole body transcriptional response, we infected Il10−/−; NF-κBEGFP mice with
C. jejuni and determined the level of NF-κB-driven EGFP expression. C. jejuni-induced
colonic EGFP expression in Il10−/−; NF-κBEGFP mice was attenuated in wortmannin-treated
mice compared to vehicle-treated mice (Figures 2C–D). In addition, wortmannin blocked C.
jejuni-induced NF-κB dependent I11β, Cxcl2 and Il17a mRNA accumulation by 50%, 77%
and 78% respectively in Il10−/−; NF-κBEGFP mice compared to vehicle-treated, infected
mice (Figure 2E). These findings indicate that PI3K signaling is involved in C. jejuni-
mediated intestinal inflammation.
PI3Kγ mediates C. jejuni-induced colitis
Since neutrophil infiltration and crypt abscesses are hallmarks of campylobacteriosis in both
human and in the Il10−/− murine model (13, 15), we speculated that signal-induced
neutrophil recruitment/activation would be important in host pathogenesis. Among PI3K
family members, the class I B PI3Kγ has been implicated in leukocyte migration and
activation. To establish the role of PI3Kγ in campylobacteriosis, germ-free Il10−/−; NF-
κBEGFP mice were gavaged with a single dose of C. jejuni (109 CFU/mouse) and i.p.
injected daily with PI3Kγ specific inhibitor AS252424 (10 mg/kg body weight) or vehicle
control (5% DMSO PBS) for 6 days. Interestingly, C. jejuni-induced colitis was reduced in
AS252424-treated Il10−/−; NF-κBEGFP mice compared to vehicle-treated mice (Figure 3A–
B). Western blot analysis (Figure 3C) demonstrated a modest reduction (Figure 3D) of AKT
phosphorylation (S473) but an evident attenuation (34%) of p70S6K phosphorylation
(T389) in colonic extracts from AS252424-treated, C. jejuni-infected Il10−/−; NF-κBEGFP
mice. In addition, induction of EGFP expression (NF-κB activity) in the colon of C. jejuni
infected Il10−/−; NF-κBEGFP mice was reduced in AS252424-treated mice compared to
control vehicle-treated mice (Figures 3C–D). We next examined the impact of PI3Kγ on
expression of NF-κB-dependent proinflammatory mediators involved in bacterial host
responses. AS252424 treatment blocked C. jejuni-induced I11β, Cxcl2 and Il17a mRNA
accumulation by 77%, 73% and 72% respectively compared to vehicle-treated, infected
Il10−/−; NF-κBEGFP mice (Figure 3E).
To gain specificity over the pharmacological targeting approach, we next utilized
Pi3kγ−/−mice. Antibiotic treatment has been shown to enhance C. jejuni colonization in Wt
mice (13). Interestingly, antibiotic-treated Il10−/− mice displayed severe colitis at 2 weeks,
but antibiotic-treated SPF Wt and Pi3kγ−/− mice were resistant to C. jejuni induced colitis
(Figures 4A and C). To enhance susceptibility of Wt and Pi3kγ−/− mice to C. jejuni-induced
colitis, we emulated the Il10 knockout phenotype by using an antibody blocking the IL-10
receptor (IL-10R). Antibiotic-treated Wt and Pi3kγ−/− mice were gavaged with C. jejuni and
then i.p. injected with anti-IL-10R antibody (500μg/mouse) every 3 days for 2 weeks. As
predicted, anti-IL-10R-treated Wt mice developed colitis following C. jejuni infection, albeit
to a slightly lower extent than Il10−/− mice (Figures 4B–C). In agreement with our
pharmacologic studies, C. jejuni-induced intestinal inflammation was strongly attenuated in
anti-IL-10R-treated Pi3kγ−/− mice compared to anti-IL-10R-treated Wt mice. No evidence
of intestinal inflammation was observed in uninfected Wt mice treated with anti-IL-10R
antibody alone. Western blot analysis demonstrated a slight reduction of AKT
phosphorylation (S473) but a strong blockade (68%) of p70S6K phosphorylation (T389) in
intestinal lysates from IL-10R-blocked, C. jejuni-infected Pi3kγ−/− mice compared to Wt
mice (Figure 4D). In accordance with the histological score, the absence of PI3Kγ strongly
reduced C. jejuni-induced I11β, Cxcl2 and Il17a mRNA accumulation (98.3%, 98.2% and
98.4% respectively) in IL-10R-blocked Pi3kγ−/− mice, compared to treated Wt mice (Figure
4E). To determine whether absence of PI3Kγ signaling is directly responsible for decreased
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C. jejuni-induced inflammatory gene expression, we isolated splenocytes from Wt and
Pi3kγ−/− mice. Interestingly, C. jejuni-induced I11β, Cxcl2, Il17a and Tnfα mRNA
expression was comparable between splenocytes obtained from Pi3kγ−/−and Wt mice
(Supplemental Figure 2). These results suggest that PI3Kγ signaling does not directly
regulate C. jejuni induced proinflammatory gene expression.
PI3Kγ mediates C. jejuni invasion
Since C. jejuni is an invasive intestinal pathogenic bacterium, we next investigated the
impact of PI3Kγ signaling on C. jejuni invasion into intra- and extra-intestinal tissues.
Following infection and treatment with the PI3Kγ inhibitor AS252424, C. jejuni DNA was
visualized in the colon of Il10−/−; NF-κBEGFP mice using fluorescence in situ hybridization
(FISH) and confocal microscopy imaging. Remarkably, while C. jejuni was abundant in
inflamed crypts and lamina propria of vehicle-treated mice, the bacterium was barely
detectable in AS252424-treated mice (Figure 5A). To assess the amount of viable C. jejuni
in intestinal and extra-intestinal tissues, we aseptically collected samples from the colon,
spleen and MLN and enumerated C. jejuni on Remel Campylobacter selective plates.
Consistent with FISH results, AS252424 treatment decreased the amount of viable C. jejuni
in colon and MLN by 97% and 90% compared to C. jejuni-infected, vehicle-treated mice
(Figure 5B). Moreover, AS252424 treatment strongly reduced the levels of viable C. jejuni
in the spleen, compared to vehicle-treated, infected mice. Again, to confirm our findings
from pharmacologic studies, we infected Pi3kγ−/− mice treated with IL-10R blocking
antibody and assessed C. jejuni invasion using FISH. C. jejuni was detected deeply inside
the intestinal section of anti-IL-10R-treated Wt mice, whereas anti-IL-10R-treated Pi3kγ−/−
mice exhibited a strong reduction in bacterial invasion into colonic tissues (Figure 5C). To
determine whether PI3Kγ signaling derived from epithelial cells directly affects C. jejuni
invasion, we infected a monolayer of murine colonic CMT-93 cells with C. jejuni in the
presence or absence of AS252424 and measured bacterial translocation using a transwell
culture system. As shown in supplemental Figure 3, PI3Kγ inhibition did not prevent C.
jejuni translocation. Taken together, these results demonstrate that C. jejuni invasion into
intestinal and extra-intestinal tissue is dependent upon functional PI3Kγ signaling, likely
originating from immune cells.
Neutrophil infiltration promotes C. jejuni-induced colitis
As previously reported, crypt abscesses and neutrophil infiltration is predominant in C.
jejuni-infected Il10−/− mice (13). As seen in Figure 6A, C. jejuni infection of Il10−/− mice
induced an average of greater than 71 colonic crypt abscesses per 100 crypts. Remarkably,
C. jejuni-induced crypt abscesses were reduced by 95% in AS252424-treated Il10−/− mice
compared to vehicle-treated mice. In accordance with this finding, MPO staining revealed
that C. jejuni-induced neutrophil infiltration into colonic tissues was strongly reduced in the
presence of AS252424 (Figure 6B). Since PI3Kγ is implicated in neutrophil migration (20),
we next evaluated peripheral blood neutrophil motility in response to the chemokine
CXCL-2 using a transwell migration assay. Migration was reduced by 64% in neutrophils
isolated from Pi3kγ−/− mice compared to Wt cells (Figures 6C and D). Together our
observations demonstrate that suppression of C. jejuni-induced colitis by pharmacologic
inhibition of PI3Kγ is associated with an impaired neutrophil migration/infiltration and
subsequent crypt abscess formation. To directly assess the role of neutrophils in C. jejuni-
induced colitis, we depleted these cells using an anti-Gr-1 antibody (i.p. every 3 days for 6
days). Depletion of neutrophils attenuated C. jejuni-induced colitis in Il10−/− mice, as
demonstrated by the significant reduction of histological scores (Figures 7A–B), which was
correlated with reduced MPO staining (Figure 7C). Numbers of colonic neutrophils were
reduced by more than 92% in anti-Gr-1 antibody-treated, C. jejuni infected mice compared
to untreated mice (Figure 7D). To determine the effect of neutrophil depletion on C. jejuni
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invasion, we visualized C. jejuni presence in colon tissues using FISH assay. Interestingly,
although neutrophils were depleted, C. jejuni invasion into the colon was strongly attenuated
(Figure 7E), suggesting that other immune cells such as macrophages and dendritic cells are
important in eliminating invading C. jejuni. Collectively, these results demonstrate that
PI3Kγ signaling is essential for C. jejuni induced intestinal inflammation, likely by
modulating neutrophil infiltration and migration into the intestinal tissues.
DISCUSSION
The molecular and cellular events leading to campylobacteriosis and its associated
pathological features remain poorly understood. We previously reported that C. jejuni
induced intestinal inflammation through mTOR signaling, a downstream target of the PI3K
pathway, which was associated with neutrophil infiltration and tissue damage (13).
However, the molecular events leading to C. jejuni induced neutrophil migration and their
functional consequence on intestinal inflammation has not been addressed. In addition,
because PI3Ks form a large family of kinases, the subunit responsible for neutrophil
activation and migration following C. jejuni infection is unclear. In this study, we uncover
the key role of innate immune cells, especially neutrophils in C. jejuni-induced intestinal
inflammation. In addition, we identified PI3Kγ signaling as key event leading to
campylobacteriosis.
Among the large family of PI3Ks, PI3Kγ is predominantly expressed in immune cells (19,
20). Disruption of PI3Kγ attenuates E. coli-induced lung injury resulting from neutrophil
infiltration (28). Similarly, a reduction of neutrophil-mediated rheumatoid arthritis is
observed in Pi3kγ−/− mice (29). Our study demonstrates that C. jejuni-induced colitis can be
alleviated by inactivation of PI3Kγ signaling using either pharmacological or genetic
manipulation.
Using FISH and culture assays, we observed that PI3Kγ signaling promotes C. jejuni
invasion into colon, MLN and spleen of Il10−/− mice. Immunohistochemistry assays
revealed massive infiltration of neutrophils into the colon following C. jejuni infection, an
effect attenuated by inactivation of PI3Kγ. Moreover, depletion of neutrophils using anti-
Gr1 antibody reduced C. jejuni induced intestinal inflammation by ~ 40%, an effect
comparable to inactivation of PI3Kγ. Taken together, our findings highlight the essential
role of PI3Kγ signaling and neutrophils in C. jejuni pathogenesis.
The contribution of innate and adaptive immune cells in host response to C. jejuni infection
is not well understood. Adaptive immunity has been documented to protect the host against
C. jejuni-induced diarrhea and intestinal inflammation in CD4 deficient HIV patients (30).
On the other hand, the plasma of C. jejuni infected patients have been shown to contain anti-
ganglioside 1 IgG (31) mimicry between the core lipooligosaccharides of C. jejuni and
human gangliosides which may be associated with the development of Guillain-Barre
Syndrome (3). Interestingly, adaptive immunity may not been essential for early intestinal
inflammation as C. jejuni induced colitis is similar between Il10−/−; Rag2−/− mice and
Il10−/− mice. This finding strongly suggests that innate immune cells are key cellular
components responsible for the acute state (~12 days) of campylobacteriosis in our model.
In addition, IHC analysis in conjunction with cell migration and depletion studies strongly
point to the key role of neutrophils in campylobacteriosis. Therefore, although persistent C.
jejuni infection triggers an adaptive immune response, the initial responses and associated
tissue damage is mediated by neutrophils.
Following enteric bacterial infection, neutrophils are rapidly recruited into intestinal tissues
where they eliminate microorganisms through phagocytosis and degranulation-mediated
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bacterial killing (32). However, overzealous neutrophil recruitment into a defined location
like intestinal crypts often leads to significant host tissue damage. Neutrophil-induced tissue
damage has been reported in non-infectious diseases such as IBD (33), lung injury (28) and
arthritis (29). In C. jejuni-infected patients, histological assessment of intestinal tissues has
revealed neutrophil infiltration and crypt abscesses (34). Using transmission electron
microscopy analysis, we previously showed that crypt microvilli are virtually destroyed by
accumulated neutrophils (13). Our current studies demonstrated that antibody-mediated
depletion of neutrophils diminished intestinal inflammation and strongly decreased crypt
abscess formation.
Although our data have identified neutrophils as key innate cells in C. jejuni mediated
pathogenesis, the molecular events leading to their recruitment into intestinal crypts is less
clear. We have shown a strong induction of the chemokine Cxcl2 in colonic lysates of C.
jejuni infected Il10−/− mice. In vitro experiments indicate that intestinal epithelial cells (12)
and splenocytes up-regulate Cxcl2 gene expression following C. jejuni infection. From these
data, one could speculate that C. jejuni invasion leads to the secretion of various chemo-
attractants including CXCL-2, from immune and non-immune cells, which then promote
recruitment of neutrophils. Interestingly, C. jejuni-induced proinflammatory gene expression
including Cxcl2 is comparable in splenocytes isolated from Pi3kγ−/− and Wt mice and
blocking PI3Kγ doesn’t attenuate C. jejuni invasion through CMT-93 epithelial monolayer.
We conclude that PI3Kγ signaling predominantly mediates its inhibitory effect through
regulation of neutrophil migration. Interestingly, although neutrophils most likely participate
in the removal of invading C. jejuni, FISH assay showed a strong decrease of the bacterium
in colonic tissues of GR-1-treated mice. This finding suggests that other innate cells such as
macrophages and dendritic cells are important for C. jejuni eradication in the colon. In this
scenario, the beneficial impact of neutrophils in C. jejuni elimination is outweighed by the
tissue destructive capacity of these innate cells and associated damage to the epithelial
barrier. It is likely that C. jejuni located in the luminal compartment profits from this
impaired barrier function to further invade the colonic tissues.
Presently, the primary treatment for campylobacteriosis resorts to antibiotics. However,
antibiotic treatment is constrained by multiple factors, including minimal effectiveness in
the late course of disease, a negligible reduction in disease duration (1.5 days), increased
antibiotic resistance, and the risk of harmful eradication of normal flora (35). Thus
alternatives to antibiotics are imperative for treating infectious enteric pathogens, and
immunotherapy targeting specific signaling pathways such as PI3Kγ may provide such an
alternative.
In summary, this report defines the critical role of PI3Kγ in mediating the pro-inflammatory
effects of C. jejuni infection. We report that PI3Kγ mediated neutrophil infiltration plays an
active role in the pathogenesis of C. jejuni infection. Accordingly, modulation of the
cellular/molecular events leading to this process could represent a new therapeutic approach
to control campylobacteriosis.
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Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Innate immune cells mediate C. jejuni induced colitis in Il10−/− mice
Cohorts of 4–7 germ-free Il10−/− and Il10−/−; Rag2−/− mice were transferred to SPF
conditions and immediately gavaged with a single dose of 109 C. jejuni/mouse. After 12
days, colons were resected for formalin-fixation, sectioning and H&E staining, or RNA
extraction for gene expression analysis. (A) Histological intestinal damage scores of C.
jejuni-induced inflammation in Il10−/− and Il10−/−; Rag2−/− mice. (B) Quantification of
histological intestinal damage score mediated by C. jejuni infection. (C) Il1β, Cxcl2 and
Il17a mRNA accumulation was quantified using an ABI 7900HT Fast Real-Time PCR
System and specific primers and data were normalized to Gapdh. All graphs depict mean ±
SEM. NS, P > 0.05. Scale bar is 200 μm. Results are representative of 3 independent
experiments.
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Figure 2. PI3K signaling pathway mediates C. jejuni-induced intestinal inflammation in Il10−/−;
NF-κBEGFP mice
Four cohorts of 4–8 germ-free Il10−/−; NF-κBEGFP mice were transferred to SPF conditions
and immediately gavaged with a single dose of C. jejuni (109/mouse) and then i.p. injected
with vehicle control (Ctl, 5% DMSO), wortmannin (wort, 1.4 mg/kg body weight) daily for
12 days. (A) H&E representation of intestinal damage. Arrow heads indicate crypt
abscesses. (B) Quantification of intestinal inflammation as histological score. (C) Western
blot for total and phosphorylated (S473) AKT and EGFP protein levels in pooled colonic
lysates of infected mice. (D) Colonic EGFP expression levels were visualized using a CCD
camera macroimaging system. (E) Il1β, Cxcl2 and Il17a mRNA accumulation was
quantified using real time PCR. All graphs depict mean ± SEM. *, P < 0.05, **, P < 0.01,
***, P < 0.001. Scale bar is 200 μm. Results are representative of 3 independent
experiments.
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Figure 3. Pharmacological inhibition of PI3Kγ blocks C. jejuni-induced intestinal inflammation
in Il10−/−; NF-κBEGFP mice
Four cohorts of 4–6 germ-free Il10−/−; NF-κBEGFP mice were transferred to SPF conditions
and infected with C. jejuni as described in Figure1. Mice were i.p. injected with vehicle (5%
DMSO) or pharmacological PI3Kγ inhibitor AS252424 (10 mg/kg body weight) daily for 6
days. (A) H&E representation of intestinal inflammation. (B) Quantitative histological score
of intestinal inflammation. (C) Western blot for total and phosphorylated (S473) AKT,
phosphorylated p70S6K (T389) and EGFP protein levels in pooled colonic lysates of
infected mice. (D) Density of Western blot bands was quantified using ImageJ and
normalized to control. (E) Colonic EGFP expression levels were visualized using a CCD
camera macroimaging system. (F) Il1β, Cxcl2 and Il17a mRNA accumulation was
quantified by real time PCR. All graphs depict mean ± SEM. *, P < 0.05, **, P < 0.01, NS,
not significant. Scale bar is 200 μm. Results are representative of 3 independent
experiments.
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Figure 4. PI3Kγ deficiency attenuates C. jejuni-induced intestinal inflammation
Eight cohorts of 4–6 Wt, Il10−/− and Pi3kγ−/−mice were treated with antibiotic for 7 days
and then gavaged with a single dose of C. jejuni (109/mouse). Wt and Pi3kγ−/−mice were
injected anti-IL-10R antibody (i.p. 0.5 mg/mouse/every 3 days) to block IL-10 receptors.
Mice were sacrificed after 14 days. (A–B) H&E representation of intestinal inflammation.
(C) Quantitative histological score of intestinal inflammation. (D) Western blot for
phosphorylated AKT (S473), phosphorylated p70S6K (T389) and total AKT protein levels
in pooled colonic lysates of infected mice. (E) Il1β, Cxcl2 and Il17a mRNA accumulation
was quantified using real time PCR. Data represent means ± SEM.*, P < 0.05. Scale bar is
200 μm. Results are representative of 2 independent experiments.
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Figure 5. PI3Kγ signaling promotes C. jejuni invasion into colon, MLN and spleen
Cohorts of 4–6 germ-free Il10−/−; NF-κBEGFP mice, SPF Wt and Pi3kγ−/− mice were
treated and infected as indicated in Figure 3 and 4. (A) C. jejuni (red dots) in colonic
sections of infected mice was detected using FISH. Scale bar is 10 μm. (B) C. jejuni
bacterial count in the colon, MLN and spleen of vehicle- or AS252424-treated mice. (C)
Presence of C. jejuni (red dots) in colonic tissue of Wt and Pi3kγ−/− mice was determined
using FISH. Data represent means ± SEM. * P < 0.05. Results are representative of 3
independent experiments.
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Figure 6. PI3Kγ mediates neutrophil accumulation and crypt abscesses in C. jejuni infected mice
Cohorts of 4–6 germ-free Il10−/−; NF-κBEGFP mice were transferred to SPF conditions and
infected/treated as indicated in Figure 3. (A) Number of crypt abscesses in C. jejuni infected
mice. (B) IHC representation of MPO positive cells (brown dots) in the colon tissue of C.
jejuni infected mice. (C) Peripheral blood neutrophils were isolated and plated in a transwell
system and cells migration in response to CXCL-2 (250 ng/mL) at the bottom well were
enumerated. Representative light images of neutrophils migrated into bottom wells. (D)
Quantitative measurements of migrated neutrophils. Lower panels (scale bar 20 μm) are
magnified images of area shown in the upper panels (scale bar 200 μm). Data represent
means ± SEM. **, P < 0.01. Results are representative of 3 independent experiments.
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Figure 7. Neutrophils enhance C. jejuni-induced colitis
Cohorts of 4–6 germ-free Il10−/−; NF-κBEGFP mice were transferred to SPF conditions and
infected as in Figure 3. Neutrophils were depleted using anti-Gr1 antibody. (A) H&E
representation of intestinal inflammation. (B) Quantitative histological score of intestinal
inflammation. (C) IHC representation of MPO positive cells (brown dots) in the colon tissue
of C. jejuni infected mice. (D) The colonic H&E stained sections were imaged (5 fields/
mouse) and neutrophils were identified based on morphological features. Data are presented
as average counts/mouse. (E) Presence of C. jejuni (red dots) in colonic tissue was
determined using FISH. Lower panels (scale bar 20 μm) are magnified images of area
shown in the upper panels (scale bar 200 μm). Data represent means ± SEM. *, P < 0.05.
Results are representative of 3 independent experiments.
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